WakeMed
Welcome,         Profile    Billing    Logout  
 29 Trials 
32 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Russell, Stuart J
LUX-Dx TRENDS, NCT04790344: Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

Active, not recruiting
N/A
525
US
Investigational LUX-Dx ICM Implant
Boston Scientific Corporation
Heart Failure
05/26
06/26
Boggess, Kim
DECIDE CGM, NCT06490874: Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT

Not yet recruiting
N/A
300
US
CGM device - Metformin group, CGM device - Insulin group
Ohio State University, The George Washington University Biostatistics Center, DexCom, Inc.
Gestational Diabetes Mellitus, Pregnancy, High Risk
12/29
12/30
Anderson, Barbara J
SAVE-FistulaS, NCT06001827: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Recruiting
N/A
200
US
SelfWrap Bioabsorbable Perivascular Wrap, SelfWrap, Untreated AVF Control, Standard of Care
VenoStent
Chronic Kidney Diseases, End Stage Renal Disease, Arteriovenous Fistula, Hemodialysis Access Failure, ESRD, Vascular Access Complication, Renal Failure, Catheter Complications, Catheter Dysfunction, Renal Insufficiency
06/25
12/27
D'Alessandro, David
BTR EFS, NCT05291884: Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

Recruiting
N/A
10
US
Impella BTR
Abiomed Inc.
Heart Failure, Acute Decompensated Heart Failure
10/23
01/24
NCT05100836: SURPASS Impella 5.5 Study

Active, not recruiting
N/A
1017
US
Impella 5.5
Abiomed Inc.
Cardiogenic Shock, Acute Decompensated Heart Failure
03/25
03/25
IMPACT, NCT05529654: IMpella-Protected CArdiaC Surgery Trial

Enrolling by invitation
N/A
100
US
Impella 5.5 with SmartAssist
Abiomed Inc.
Left Ventricular Dysfunction
06/25
09/25
NCT05047068: OCS Heart Perfusion Post-Approval Registry

Active, not recruiting
N/A
350
US
OCS Heart System
TransMedics
Transplant
12/25
12/29
OHP-II, NCT05915299: US National OCS Heart Perfusion (OHP) Registry

Recruiting
N/A
100000
US
OCS Heart
TransMedics
Heart Transplant
08/29
08/33
LeAAPS, NCT05478304: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Recruiting
N/A
6500
Europe, Canada, US
AtriClip LAA Exclusion System
AtriCure, Inc., Population Health Research Institute
Ischemic Stroke, Systemic Embolism
12/31
04/32
Rao, Siddhartha
RESTOR-1, NCT04663867: AngioSafe Peripheral CTO Crossing System Study ( Study)

Completed
N/A
133
US
AngioSafe Peripheral CTO Crossing System
AngioSafe, Inc., Veranex, Inc.
Peripheral Artery Occlusion, Peripheral Arterial Disease
04/23
06/23
TBD, TBD
INFRONT-3, NCT04374136 / 2019-004066-18: A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia

Active, not recruiting
3
110
Europe, Canada, US, RoW
AL001, Placebo, Open label - AL001
Alector Inc.
Frontotemporal Dementia
09/25
10/27
NCT04105452: Study to Evaluate PL8177 in Subjects With Non Infectious Uveitis (NIU)

Not yet recruiting
2
40
NA
PL8177
Palatin Technologies
Non-infectious Uveitis
05/20
09/20
NEO-SURG, NCT06449313: Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement

Not yet recruiting
2
21
US
Cemiplimab-Rwlc, Libtayo
Georgetown University, Regeneron Pharmaceuticals
Non-small Cell Lung Cancer Stage III
12/27
09/32
INVOKE-2, NCT04592874 / 2019-001476-11: A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

Completed
2
381
Europe, Canada, US, RoW
AL002, Placebo
Alector Inc., AbbVie
Alzheimer Disease
08/24
09/24
NCT05744401 / 2022-002987-57: A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

Active, not recruiting
2
188
Europe, Canada, US, RoW
AL002
Alector Inc., AbbVie
Alzheimer's Disease
09/25
12/25
CAR, NCT06215105: Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices

Enrolling by invitation
N/A
750
US
Intracranial Aneurysm Devices
Microvention-Terumo, Inc.
Aneurysm Cerebral
01/29
01/29
NCT05876078: DORAYA-HF OUS Assessment of the Doraya Catheter for the Treatment of ADHF Patients With Insufficient Response to Diuretics

Recruiting
N/A
35
Europe, RoW
Doraya catheter
Revamp Medical Ltd.
Acute Decompensated Heart Failure
12/25
04/26
NCT03173664: Post-Approval Study With the KAMRA Inlay

Not yet recruiting
N/A
529
NA
KAMRA Inlay
AcuFocus, Inc.
Presbyopia
01/26
01/26
GPS Registry, NCT05027685: The "Global Paradise System" Registry

Recruiting
N/A
3000
Europe, RoW
The Paradise Ultrasound Renal Denervation System
ReCor Medical, Inc.
Hypertension
12/30
12/31
C19REG, NCT04331860: COVID-19 Public Image Registry

Recruiting
N/A
500000
US
No intervention
RAD-AID International, BioClinica, Inc., Google Inc.
COVID-19
03/25
03/25
Silver, Marc
NCT04496518: Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

Active, not recruiting
N/A
2200
Europe, US
Intrinsic Antitachycardia Pacing (iATP) Therapy
Medtronic
Ventricular Tachycardia
01/25
01/27
NCT04489225: Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

Active, not recruiting
N/A
2200
Europe, US
Observational
Medtronic
Heart Failure
01/25
01/27
ASQ, NCT04024943: Personalized Therapy Study - Attain Stability Quad Post-Approval Study

Active, not recruiting
N/A
1092
Europe, US
Quadripolar LV Lead, Medtronic CRT-P, Medtronic CRT-D
Medtronic
Heart Failure
01/27
04/27
Norton, Rhonda
NCT05614869: Continuous Treatment With PREVENA Therapy for 14 Days

Recruiting
N/A
353
US
Prevena Plus Incision Management System with Prevena Dressings
KCI USA, Inc, Solventum US LLC, 3M
Abdominal Surgery, Orthopedic Surgery, Cardiovascular Surgery, Vascular Surgery
03/27
05/27
LeAAPS, NCT05478304: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Recruiting
N/A
6500
Europe, Canada, US
AtriClip LAA Exclusion System
AtriCure, Inc., Population Health Research Institute
Ischemic Stroke, Systemic Embolism
12/31
04/32
Wood, Frances
ISO-SHOCK, NCT04876040: Incorporating Supersaturated Oxygen in Shock

Withdrawn
N/A
60
US
SSO2 Downstream System, PCI + Impella
TherOx
Cardiogenic Shock, STEMI
01/24
06/25
Williams, Judson
LeAAPS, NCT05478304: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Recruiting
N/A
6500
Europe, Canada, US
AtriClip LAA Exclusion System
AtriCure, Inc., Population Health Research Institute
Ischemic Stroke, Systemic Embolism
12/31
04/32
Dewan, Maya
pediRES-Q, NCT02708134: Quality of Pediatric Resuscitation in a Multicenter Collaborative

Recruiting
N/A
5000
Europe, Canada, Japan, US, RoW
Children's Hospital of Philadelphia, Zoll Medical Corporation
Cardiac Arrest, Cardiopulmonary Arrest
01/28
01/30
Treasure, Charles
MUIR-3, NCT06347133: Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

Recruiting
3
1328
Europe, Canada, US, RoW
Plozasiran Injection, ARO-APOC3, Placebo
Arrowhead Pharmaceuticals
Hypertriglyceridemia
07/26
10/26
SHASTA-3, NCT06347003: Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia

Recruiting
3
405
Europe, Canada, US, RoW
Plozasiran Injection, ARO-APOC3, Placebo
Arrowhead Pharmaceuticals
Severe Hypertriglyceridemia
07/26
10/26
VICTORION-1 PREVENT, NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Active, not recruiting
3
14013
Europe, Canada, US, RoW
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml
Novartis Pharmaceuticals
Primary Prevention of Atherosclerotic Cardiovascular Disease
04/29
04/29
LUX-Dx TRENDS, NCT04790344: Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

Active, not recruiting
N/A
525
US
Investigational LUX-Dx ICM Implant
Boston Scientific Corporation
Heart Failure
05/26
06/26

Download Options